Revision of Cytomegalovirus Immunoglobulin M Antibody Titer Cutoff in a Maternal Antibody Screening Program in Japan: A Cohort Comparison Involving a Total of 32,000 Pregnant Women
Viruses · 2023
DOI: 10.3390/v15040962 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Asa Kitamura und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Mie University Graduate School of Medicine, Tsu 514-8507, Japan. Hauptthemen laut MEDLINE: Pregnancy Complications, Infectious, Cytomegalovirus Infections. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development (AMED), JSPS KAKENHI.
Abstract (Originalsprache)
Cytomegalovirus (CMV) is associated with congenital infections. We aimed to validate the revised CMV immunoglobulin (Ig) M titer cutoff for IgG avidity measurements as a reflex test in maternal screening to identify women with primary CMV infection and newborn congenital cytomegalovirus (cCMV). We screened maternal CMV antibodies (the Denka assay) in Japan, from 2017 to 2019, using a revised IgM cutoff (≥4.00 index). Participants were tested for IgG and IgM antibodies, and for IgG avidity if IgM levels exceeded the cutoff. We compared these with corresponding results from 2013 to 2017 based on the original cutoff (≥1.21) and recalculated using the revised cutoff. Newborn urine CMV DNA tests were performed for women with low avidity (≤35.0%). Among 12,832 women screened in 2017–2019, 127 (1.0%) had IgM above the revised cutoff. Thirty-five exhibited low avidity, and seven infants developed cCMV. Of 19,435 women screened in 2013–2017, 184 (1.0%) had IgM above the revised cutoff, 67 had low avidity, and 1 had cCMV. The 2017–2019 results were not significantly different from the 2013–2017 results. The revised IgM cutoff improves maternal screening in identifying primary infection and newborn cCMV; however, further study related to other assays than Denka is required.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Mie University Graduate School of Medicine, Tsu 514-8507, Japan.
- Department of Obstetrics and Gynecology, National Hospital Organization Mie Chuo Medical Center, Tsu 514-8507, Japan.
- Department of Obstetrics and Gynecology, Kurashiki Medical Center, Okayama 710-8522, Japan.
- Clinical Laboratory, Mie University Hospital, Tsu 514-8507, Japan.
- Research Center for Disease Control, Aisenkai Nichinan Hospital, Miyazaki 887-0034, Japan.
- Institute for Clinical Research, National Hospital Organization Mie National Hospital, Tsu 514-8507, Japan.
ORCID-Profile: Kuniaki Toriyabe, Shigeru Suga
Förderung
- Japan Agency for Medical Research and Development (AMED)
- JSPS KAKENHI
Zitieren
APA
Kitamura, A., Toriyabe, K., Hagimoto-Akasaka, M., Hamasaki-Shimada, K., Ikejiri, M., Minematsu, T., Suga, S., Kondo, E., Kihira, M., Morikawa, F., & Ikeda, T. (2023). Revision of Cytomegalovirus Immunoglobulin M Antibody Titer Cutoff in a Maternal Antibody Screening Program in Japan: A Cohort Comparison Involving a Total of 32,000 Pregnant Women. Viruses. https://doi.org/10.3390/v15040962
Vancouver
Kitamura A, Toriyabe K, Hagimoto-Akasaka M, Hamasaki-Shimada K, Ikejiri M, Minematsu T, et al. Revision of Cytomegalovirus Immunoglobulin M Antibody Titer Cutoff in a Maternal Antibody Screening Program in Japan: A Cohort Comparison Involving a Total of 32,000 Pregnant Women. Viruses. 2023. doi:10.3390/v15040962
BibTeX
@article{Kitamura2023,
author = {Kitamura, Asa and Toriyabe, Kuniaki and Hagimoto-Akasaka, Miki and Hamasaki-Shimada, Kyoko and Ikejiri, Makoto and Minematsu, Toshio and Suga, Shigeru and Kondo, Eiji and Kihira, Masamichi and Morikawa, Fumihiro and Ikeda, Tomoaki},
title = {Revision of Cytomegalovirus Immunoglobulin M Antibody Titer Cutoff in a Maternal Antibody Screening Program in Japan: A Cohort Comparison Involving a Total of 32,000 Pregnant Women},
journal = {Viruses},
year = {2023},
doi = {10.3390/v15040962}
}
EUVIMED